Hims & Hers Q3 Preview: Key Metrics I Want To See For Beating 2030 Guidance (HIMS)

When I started covering Hims & Hers Health, Inc. (NYSE: HIMS ) in March this year, the company was trading at a cheap valuation due to the market seeing it as little more thanI either put my money into low cost funds or in single stocks that (I think) are asymmetric bets. My portfolio is roughly 50/50 between the two. I like to write about Macro and Fundamentals, with the (painful) awareness that Momentum and Sentiment are what really matters. That’s the reason I never try to time the market and I only buy ...